National Cancer Institute; Notice of Meeting, 62299-62300 [E8-24832]
Download as PDF
<![CDATA[
62299
Federal Register / Vol. 73, No. 203 / Monday, October 20, 2008 / Notices
each notification will take
approximately 8 hours to prepare and
submit to FDA.
The draft guidance also permits the
transfer of a priority review voucher
from one sponsor to another, and states
that each transfer should be
documented with a letter of transfer. We
estimate that we will receive
approximately two letters indicating the
transfer of a voucher from two
application holders, and two letters
from two new voucher owners
acknowledging the transfer, and that it
will take approximately 8 hours to
prepare and submit each letter to FDA.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
Reporting Under Section 1102 of
FDAAA
No. of
Respondents
No. responses
per Respondent
Total
Responses
Hours Per
Response
Total Hours
Priority review voucher request
5
1
5
8
40
Notifications of intent to use a
voucher
5
1
5
8
40
Letters indicating the transfer of a
voucher
2
1
2
8
16
Letters acknowledging the receipt
of a transferred voucher.
2
1
2
8
16
Total
1 There
112
are no capital costs or operating and maintenance costs associated with this collection of information.
III. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. Electronic
comments or submissions will be
accepted by FDA only through FDMS at
https://www.regulations.gov.
Dated: October 1, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–24932 Filed 10–17–08; 8:45 am]
BILLING CODE 4160–01–S
mstockstill on PROD1PC66 with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Aug<31>2005
16:42 Oct 17, 2008
Jkt 217001
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors for Basic
Sciences National Cancer Institute. The
meeting will be closed to the public as
indicated below in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences National
Cancer Institute.
Date: November 18, 2008.
Time: 9 a.m. to 2:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
National Cancer Institute, 9000 Rockville
Pike, Building 31, Conference Room 6,
Bethesda, MD 20892.
Contact Person: Florence E. Farber, PhD,
Executive Secretary, Office of the Director,
National Cancer Institute, National Institutes
of Health, 6116 Executive Boulevard, Room
2205, Bethesda, MD 20892, 301–496–7628,
ff6p@nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsc/bs/bs.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–24830 Filed 10–17–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
President’s Cancer Panel.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
E:\FR\FM\20OCN1.SGM
20OCN1
62300
Federal Register / Vol. 73, No. 203 / Monday, October 20, 2008 / Notices
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C., as
amended, because the premature
disclosure of these discussions would
be likely to significantly frustrate
implementation of recommendations.
Name of Committee: President’s Cancer
Panel.
Date: December 4, 2008.
Open: December 4, 2008, 8 a.m.–3 p.m.
Agenda: Environmental Factors in Cancer.
Place: Doubletree Guest Suites, 181 Church
Street, Charleston, SC 29401.
Closed: December 4, 2008, 4 p.m.–7 p.m.
Agenda: Discussion of testimony given in
open session on Environmental Factors in
Cancer; consideration of thematic concepts
for the 2009/2010 series.
Place: Doubletree Guest Suites, 181 Church
Street, Charleston, SC 29401.
Contact Person: Abby Sandler, PhD,
Executive Secretary, National Cancer
Institute, National Institutes of Health,
Building 6116, Room 220, MSC 8349, 6116
Executive Boulevard, Bethesda, MD 20892,
301/451–9399.
Any interested person may file written
comments with the committee by forwarding
the comments to the Contact Person listed on
this notice. The comments should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/pcp/pcp.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–24832 Filed 10–17–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on PROD1PC66 with NOTICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
VerDate Aug<31>2005
16:42 Oct 17, 2008
Jkt 217001
Board of Scientific Counselors for
Clinical Sciences and Epidemiology
National Cancer Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology National Cancer Institute.
Date: November 17, 2008.
Time: 9 a.m. to 4 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
National Cancer Institute, 9000 Rockville
Pike, Building 31, Conference Room 10,
Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, PhD,
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, 6116 Executive
Boulevard, Room 2201, Bethesda, MD 20892,
(301) 496–7628, wojcikb@mail.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/bsc.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–24833 Filed 10–17–08; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, R21 Conflict
Review.
Date: November 17, 2008.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy Two, 6707 Democracy Boulevard,
Room 401, Bethesda, MD 20817. (Telephone
conference call)
Contact Person: Laurie Friedman Donze,
PhD, Scientific Review Officer, Office of
Scientific Review, National Center for
Complementary, and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–402–1030,
donzel@mail.nih.gov.
Dated: October 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–24829 Filed 10–17–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\20OCN1.SGM
20OCN1
]]>Agencies
[Federal Register Volume 73, Number 203 (Monday, October 20, 2008)]
[Notices]
[Pages 62299-62300]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-24832]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the President's Cancer Panel.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should
[[Page 62300]]
notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as
amended, because the premature disclosure of these discussions would be
likely to significantly frustrate implementation of recommendations.
Name of Committee: President's Cancer Panel.
Date: December 4, 2008.
Open: December 4, 2008, 8 a.m.-3 p.m.
Agenda: Environmental Factors in Cancer.
Place: Doubletree Guest Suites, 181 Church Street, Charleston,
SC 29401.
Closed: December 4, 2008, 4 p.m.-7 p.m.
Agenda: Discussion of testimony given in open session on
Environmental Factors in Cancer; consideration of thematic concepts
for the 2009/2010 series.
Place: Doubletree Guest Suites, 181 Church Street, Charleston,
SC 29401.
Contact Person: Abby Sandler, PhD, Executive Secretary, National
Cancer Institute, National Institutes of Health, Building 6116, Room
220, MSC 8349, 6116 Executive Boulevard, Bethesda, MD 20892, 301/
451-9399.
Any interested person may file written comments with the
committee by forwarding the comments to the Contact Person listed on
this notice. The comments should include the name, address,
telephone number and, when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: October 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-24832 Filed 10-17-08; 8:45 am]
BILLING CODE 4140-01-P
